Sign in
CompletedNo phase

Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain

Key facts

Who runs it
University of Colorado, Denver
Where
Denver, United StatesSee the site
Trial code
Status
Completed
People taking part
52 people enrolled
Started
1 Mar 2018
Ended
30 Jun 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • STOP Therapy Treatment group
  • Treatment as usual (TAU) group
Record updated
27 March 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • 18-65 years old
  • Willing to adhere to study protocol including treatment sessions and assessments
  • Individuals have a history of co-morbid opioid use disorder and chronic pain
  • Cognitively able to participate and give informed consent

Who cannot take part

  • Acute or unstable psychotic disorder
  • Psychiatric hospitalization or suicide attempt in the past 3 months
  • Patient has been diagnosed with an unstable cardiovascular condition including: myocardial infarction, arrhythmia, or poorly controlled hypertension in the past 3 months
  • Over the age of 65 since evidence suggests pain perception alters with age
  • Lack of verbal and written English fluency

Where in United States

  • University of Colorado DenverDenver, United States

About the trial

What the trial wants to find out

The public health relevance of this proposed project is substantial given the current opioid abuse epidemic as identified by the Centers for Disease Control (CDC). This study finalizes and tests a new psychotherapy treatment that is designed to treat chronic pain and opioid addiction at the same time in a format that could be easily used in a community addiction treatment setting. Final products of the study will yield an integrated STOP (Self-regulation/Cognitive-behavioral therapy (CBT) Therapy for Opioid addiction and Pain) manual guided protocol, patient workbook, and therapist training protocol.

The 2 groups in the trial

  • STOP Therapy Treatment groupTreatment being tested

    Self-regulation Treatment for Opioid addiction and Pain (STOP) is a 12-week, rolling entry group therapy protocol that underwent initial development in a previous K23 study. Treatment consists of weekly 90-minute CBT+SR (Self Regulation) treatment with skill building exercises for co-morbid opioid addiction and pain. STOP will be provided in lieu of TAU (Treatment as Usual) group therapy.

  • Treatment as usual (TAU) groupExisting treatment, for comparison

    Psychotherapy for Addiction in conjunction with medication assisted treatment. Standard community treatment for opioid addiction consists of 90-minute weekly rolling entry addiction treatment for 12 weeks to allow for the learning and rehearsal of skills designed to reduce relapse.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
27 March 2025